BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1617 related articles for article (PubMed ID: 9302396)

  • 1. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
    Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
    Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
    Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.
    Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A
    J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum levels of the carboxyterminal telopeptide of type I collagen in patients with thyroid disorders].
    Conti A; Monzani M; Persani L; Sartorio A
    Minerva Endocrinol; 1994 Sep; 19(3):127-31. PubMed ID: 7799894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating telopeptide type I is a peripheral marker of thyroid hormone action in hyperthyroidism and during levothyroxine suppressive therapy.
    Loviselli A; Mastinu R; Rizzolo E; Massa GM; Velluzzi F; Sammartano L; Mela Q; Mariotti S
    Thyroid; 1997 Aug; 7(4):561-6. PubMed ID: 9292943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
    Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
    Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST.
    Beck-Peccoz P; Roncoroni R; Mariotti S; Medri G; Marcocci C; Brabant G; Forloni F; Pinchera A; Faglia G
    J Clin Endocrinol Metab; 1990 Jul; 71(1):19-25. PubMed ID: 2370293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism.
    Fisher DA; Schoen EJ; La Franchi S; Mandel SH; Nelson JC; Carlton EI; Goshi JH
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2722-7. PubMed ID: 10946871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.
    Ferretti E; Persani L; Jaffrain-Rea ML; Giambona S; Tamburrano G; Beck-Peccoz P
    J Clin Endocrinol Metab; 1999 Mar; 84(3):924-9. PubMed ID: 10084572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on patients with a discrepancy between free thyroid hormones and thyrotropin values].
    Hisaoka T; Iino S; Saitoh H; Yoshimura H; Ishikawa N; Momotani N; Ito K
    Nihon Naibunpi Gakkai Zasshi; 1994 Aug; 70(6):563-72. PubMed ID: 7958106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women.
    Baqi L; Payer J; Killinger Z; Susienkova K; Jackuliak P; Cierny D; Langer P
    Endocr Regul; 2010 Jan; 44(1):9-15. PubMed ID: 20151763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
    Ito M; Miyauchi A; Kang S; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nakamura H; Amino N
    Eur J Endocrinol; 2015 Sep; 173(3):333-40. PubMed ID: 26077156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in circulating thyroid hormone levels and systolic time intervals in acute hypothyroidism.
    Price DE; O'Malley BP; Northover B; Rosenthal FD
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):67-9. PubMed ID: 1889141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas.
    Gancel A; Vuillermet P; Legrand A; Catus F; Thomas F; Kuhn JM
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):421-8. PubMed ID: 8187308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
    Guo CY; Weetman AP; Eastell R
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.